Hormone Testing in Midlife: What Is Worth Checking

Not knowing what is happening in your own body is its own symptom. Testing can answer part of the question, as long as you know which part it can answer.

The uncomfortable truth about sex hormone testing

In perimenopause, estradiol and FSH swing dramatically from week to week and even day to day. A level drawn on a Tuesday can look entirely different from one drawn ten days later. This is why professional guidelines do not recommend diagnosing perimenopause by blood test in women over 45 who have typical symptoms. The pattern of your cycles and symptoms is more reliable than the number.

That does not make testing useless. It makes it useful for specific questions rather than as a general scan.

A single estradiol level in perimenopause is a photograph of a moving object. The symptom history is the film.

When sex hormone testing genuinely helps

• Under 45 with absent or irregular periods, where premature or early menopause needs to be confirmed or excluded.
• After hysterectomy without ovary removal, where there is no cycle to observe.
• Symptoms suggesting another endocrine cause, such as elevated prolactin or an androgen excess.
• Monitoring certain hormone therapy formulations, where levels guide dosing.

The panel that usually earns its place

For a woman in her forties feeling unwell without a clear cause, the more informative tests are frequently not the sex hormones at all:

• Thyroid function, because thyroid disease mimics perimenopause closely and is common.
• Complete blood count and ferritin, because heavy cycles deplete iron and iron deficiency explains fatigue, hair shedding, and breathlessness.
• HbA1c and a lipid panel, because cardiovascular risk changes measurably in this decade and this is the window where prevention works.
• Vitamin D and B12.
• Liver and kidney function, which also inform what can safely be prescribed.

Tests to be skeptical of

Salivary and dried urine hormone panels are widely marketed and poorly standardized, and results do not reliably correspond to what is happening in tissue. Large multi hormone panels sold directly to consumers tend to generate findings that require explanation without changing treatment. Testing that leads to compounded hormone regimens dosed to a target number is not supported by evidence, and dosing should follow symptoms.

What to bring instead

Three to six months of tracked cycle dates and flow. A written symptom list with rough timing and severity. A current medication and supplement list. Your family history of heart disease, osteoporosis, breast cancer, and blood clots. That history determines treatment options more than any laboratory value will.